Cadrenal Therapeutics Files For Resale From Time To Time Of Up To 8.85M Shares Of Common Stock By The Selling Stockholders
Portfolio Pulse from Happy Mohamed
Cadrenal Therapeutics has filed for the resale of up to 8.85 million shares of common stock by the selling stockholders, according to a SEC filing.
July 24, 2023 | 1:19 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Cadrenal Therapeutics' filing for resale of up to 8.85M shares could potentially dilute the value of existing shares.
The filing for resale of a significant number of shares by Cadrenal Therapeutics could lead to dilution of the value of existing shares. This is because the increase in supply of shares, if not met with an equivalent increase in demand, could lead to a decrease in the share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100